Cimpress PLC has a consensus price target of $111.5, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Barrington Research, Barrington Research, and Truist Securities on May 7, 2024, February 5, 2024, and February 2, 2024. With an average price target of $112 between Barrington Research, Barrington Research, and Truist Securities, there's an implied 26.81% upside for Cimpress PLC from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/07/2024 | Buy Now | 27.94% | Barrington Research | Kevin Steinke | $113 → $113 | Maintains | Outperform | Get Alert |
02/05/2024 | Buy Now | 27.94% | Barrington Research | Kevin Steinke | $100 → $113 | Maintains | Outperform | Get Alert |
02/02/2024 | Buy Now | 24.55% | Truist Securities | Youssef Squali | $90 → $110 | Maintains | Buy | Get Alert |
01/03/2024 | Buy Now | 13.22% | Barrington Research | Kevin Steinke | $91 → $100 | Maintains | Outperform | Get Alert |
09/15/2023 | Buy Now | 1.9% | Truist Securities | Youssef Squali | $87 → $90 | Maintains | Buy | Get Alert |
09/13/2023 | Buy Now | -1.49% | Truist Securities | Youssef Squali | → $87 | Reiterates | Buy → Buy | Get Alert |
07/31/2023 | Buy Now | 3.03% | Barrington Research | Kevin Steinke | $66 → $91 | Reiterates | Outperform → Outperform | Get Alert |
07/28/2023 | Buy Now | -1.49% | Truist Securities | Youssef Squali | $68 → $87 | Maintains | Buy | Get Alert |
05/25/2023 | Buy Now | -25.27% | Barrington Research | Kevin Steinke | → $66 | Reiterates | → Outperform | Get Alert |
05/01/2023 | Buy Now | -25.27% | Barrington Research | Kevin Steinke | $57 → $66 | Maintains | Outperform | Get Alert |
04/28/2023 | Buy Now | -23.01% | Truist Securities | Youssef Squali | $50 → $68 | Maintains | Buy | Get Alert |
03/27/2023 | Buy Now | -43.39% | Truist Securities | Youssef Squali | $45 → $50 | Maintains | Buy | Get Alert |
01/27/2023 | Buy Now | -49.05% | Truist Securities | Youssef Squali | $85 → $45 | Maintains | Buy | Get Alert |
10/31/2022 | Buy Now | -35.46% | Barrington Research | Kevin Steinke | $76 → $57 | Maintains | Outperform | Get Alert |
10/28/2022 | Buy Now | -3.76% | Truist Securities | Youssef Squali | $115 → $85 | Maintains | Buy | Get Alert |
The latest price target for Cimpress (NASDAQ: CMPR) was reported by Barrington Research on May 7, 2024. The analyst firm set a price target for $113.00 expecting CMPR to rise to within 12 months (a possible 27.94% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Cimpress (NASDAQ: CMPR) was provided by Barrington Research, and Cimpress maintained their outperform rating.
There is no last upgrade for Cimpress.
There is no last downgrade for Cimpress.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cimpress, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cimpress was filed on May 7, 2024 so you should expect the next rating to be made available sometime around May 7, 2025.
While ratings are subjective and will change, the latest Cimpress (CMPR) rating was a maintained with a price target of $113.00 to $113.00. The current price Cimpress (CMPR) is trading at is $88.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.